Alpha 2.0
Login Register
» Authors » Joan Walker

Joan Walker

Explore the profile of Joan Walker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 1296
Followers 0
Related Specialties
Oncology
Gynecology & Obstetrics
Microbiology
Top 10 Co-Authors
Mark Schiffman
Nicolas Wentzensen
S Terence Dunn
Rosemary Zuna
Michael A Gold
Rosemary E Zuna
Michael Cullen
Lisa Mirabello
Philip E Castle
Meredith Yeager
Published In
Gynecol Oncol
Int J Cancer
Am J Obstet Gynecol
J Natl Cancer Inst
Obstet Gynecol
Affiliations
Soon will be listed here.
Recent Articles
1.
In-person, pick up or delivery? Evolving patterns of household spending behavior through the early reopening phase of the COVID-19 pandemic
Said M, Tahlyan D, Stathopoulos A, Mahmassani H, Walker J, Shaheen S
Travel Behav Soc . 2023 Jan; 31:295-311. PMID: 36643616
Consumer reactions to COVID-19 pandemic disruptions have been varied, including modifications in spending frequency, amount, product categories and delivery channels. This study analyzes spending data from a sample of 720...
2.
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors
Thomson C, Crane T, Miller A, Gold M, Powell M, Bixel K, et al.
Gynecol Oncol . 2023 Jan; 170:11-18. PMID: 36608382
Objective: The Lifestyle Intervention for oVarian cancer Enhanced Survival (LIVES) is a national study of a combined diet and physical activity intervention for stage II-IV ovarian cancer survival, an under-represented...
3.
For whom did telework not work during the Pandemic? understanding the factors impacting telework satisfaction in the US using a multiple indicator multiple cause (MIMIC) model
Tahlyan D, Said M, Mahmassani H, Stathopoulos A, Walker J, Shaheen S
Transp Res Part A Policy Pract . 2022 Dec; 155:387-402. PMID: 36570728
The COVID-19 pandemic required employees and businesses across the world to rapidly transition to work from home over extended periods, reaching what is likely the upper bound of telework in...
4.
Public transit use in the United States in the era of COVID-19: Transit riders' travel behavior in the COVID-19 impact and recovery period
Parker M, Li M, Bouzaghrane M, Obeid H, Hayes D, Frick K, et al.
Transp Policy (Oxf) . 2022 Dec; 111:53-62. PMID: 36568351
COVID-19 has upended travel across the world, disrupting commute patterns, mode choices, and public transit systems. In the United States, changes to transit service and reductions in passenger volume due...
5.
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study
Chan J, Tian C, Kesterson J, Richardson M, Lin K, Tewari K, et al.
Gynecol Oncol . 2022 Oct; 167(3):429-435. PMID: 36244828
Objectives: To determine the clinical and prognostic significance of CA-125 trends prior to, during, and after chemotherapy in high-risk early-stage epithelial ovarian cancer patients. Methods: All patients were enrolled in...
6.
Computer-Animated Relational Agents in Human Papillomavirus Vaccination Education
Gogoi R, Wallbillich J, Winer I, Morris R, Ritchie C, Larson S, et al.
Obstet Gynecol . 2022 May; 139(5):913-915. PMID: 35576351
No abstract available.
7.
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management
Mix J, Saraiya M, Hallowell B, Befano B, Cheung L, Unger E, et al.
J Natl Cancer Inst . 2022 Feb; 114(6):845-853. PMID: 35176161
Background: Racial and ethnic variations in attribution of cervical precancer and cancer to human papillomavirus (HPV) types may result in different HPV vaccine protection, screening test coverage, and clinical management....
8.
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
Mullany S, Miller D, Robison K, Levinson K, Lee Y, Yamada S, et al.
Gynecol Oncol Rep . 2020 Sep; 34:100627. PMID: 32953961
Submicron particles (~800 nm) of paclitaxel (SPP) contain 1-2 billion molecules of pure drug that release tumoricidal levels of paclitaxel over many weeks. This study compared two dose-levels of SPP...
9.
Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening
Wentzensen N, Lahrmann B, Clarke M, Kinney W, Tokugawa D, Poitras N, et al.
J Natl Cancer Inst . 2020 Jun; 113(1):72-79. PMID: 32584382
Background: With the advent of primary human papillomavirus testing followed by cytology for cervical cancer screening, visual interpretation of cytology slides remains the last subjective analysis step and suffers from...
10.
Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention
Pinheiro M, Gage J, Clifford G, Demarco M, Cheung L, Chen Z, et al.
Int J Cancer . 2020 May; 147(10):2677-2686. PMID: 32363580
HPV35 has been found in only ∼2% of invasive cervical cancers (ICC) worldwide but up to 10% in Sub-Saharan Africa, warranting further investigation and consideration of impact on preventive strategies....